AIRLINK 173.40 Decreased By ▼ -2.33 (-1.33%)
BOP 13.20 Increased By ▲ 0.08 (0.61%)
CNERGY 7.40 Decreased By ▼ -0.14 (-1.86%)
FCCL 43.54 Decreased By ▼ -0.37 (-0.84%)
FFL 14.90 Decreased By ▼ -0.11 (-0.73%)
FLYNG 26.45 Decreased By ▼ -0.45 (-1.67%)
HUBC 129.69 Decreased By ▼ -0.54 (-0.41%)
HUMNL 13.35 Increased By ▲ 0.01 (0.07%)
KEL 4.43 Decreased By ▼ -0.07 (-1.56%)
KOSM 6.00 Decreased By ▼ -0.06 (-0.99%)
MLCF 55.10 Decreased By ▼ -0.93 (-1.66%)
OGDC 215.16 Increased By ▲ 0.39 (0.18%)
PACE 5.95 Decreased By ▼ -0.03 (-0.5%)
PAEL 41.40 Increased By ▲ 0.50 (1.22%)
PIAHCLA 16.70 Increased By ▲ 0.38 (2.33%)
PIBTL 9.58 Decreased By ▼ -0.17 (-1.74%)
POWER 11.65 Decreased By ▼ -0.11 (-0.94%)
PPL 182.94 Increased By ▲ 1.46 (0.8%)
PRL 34.17 Decreased By ▼ -0.05 (-0.15%)
PTC 22.88 Decreased By ▼ -0.18 (-0.78%)
SEARL 94.00 Decreased By ▼ -1.72 (-1.8%)
SILK 1.17 Increased By ▲ 0.03 (2.63%)
SSGC 35.58 Increased By ▲ 0.13 (0.37%)
SYM 15.80 Increased By ▲ 0.05 (0.32%)
TELE 7.80 Decreased By ▼ -0.07 (-0.89%)
TPLP 10.88 Decreased By ▼ -0.10 (-0.91%)
TRG 60.60 Increased By ▲ 0.10 (0.17%)
WAVESAPP 10.75 Decreased By ▼ -0.06 (-0.56%)
WTL 1.33 Decreased By ▼ -0.02 (-1.48%)
YOUW 3.79 Increased By ▲ 0.02 (0.53%)
BR100 12,084 Increased By 30.8 (0.26%)
BR30 36,591 Increased By 123.8 (0.34%)
KSE100 114,135 Decreased By -221.2 (-0.19%)
KSE30 35,233 Decreased By -114 (-0.32%)

WASHINGTON: Sales of Juul e-cigarettes were blocked by the US Food and Drug Administration on Thursday, in a major blow to the once high-flying firm whose products have been tied to a surge in teenage vaping.

The agency said the applications “lacked sufficient evidence” to show that sale of the products would be appropriate for public health, following a nearly two-year-long review of data provided by the company.

Some of the findings raised concerns due to insufficient and conflicting data, including whether potentially harmful chemicals could leach out of the Juul pods, the FDA said.

“We respectfully disagree with the FDA’s findings ... intend to seek a stay and are exploring all of our options under the FDA’s regulations and the law, including appealing the decision and engaging with our regulator,” said Joe Murillo, chief regulatory officer at Juul.

The company said it had appropriately characterized the toxicological profile of its products and that the data met the statutory standard of being “appropriate for the protection of the public health.”

Comments

Comments are closed.